Protagonist Therapeutics, Inc. · NASDAQ:PTGX
Waddill William D. sold 9,000 Protagonist Therapeutics, Inc. shares (Form 4)
Traded Jun 10, 2026 · Filed Jun 11, 2026
On Jun 10, 2026, Waddill William D. (Director) sold 9,000 Protagonist Therapeutics, Inc. shares at US$107.68 for US$969K under a trading plan, leaving 7,825 shares. Filed Jun 11, 2026 (Form 4).
- Sold
- 9,000 shares
- Price
- US$107.68
- Value
- US$969K
- Holding after
- 7,825 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 10, 2026 | Common Stock | Option exercise | 3,000 | US$11.80 | 10,825 | Direct |
| Jun 10, 2026 | Common Stock | Option exercise | 6,000 | US$16.54 | 16,825 | Direct |
| Jun 10, 2026 | Common Stock | Sale | 9,000 | US$107.68 | 7,825 | Direct |
Source
Related
- Protagonist Therapeutics, Inc.
- Waddill William D.
- Protagonist Therapeutics, Inc. shareholders
- Form 4 · Waddill William D. · Jun 25, 2026
- Form 4 · Waddill William D. · Jun 1, 2026
- Form 4 · Ali Asif · Oct 2, 2026
- Form 4 · Patel Dinesh V Ph D · Sep 10, 2026
- Form 4 · Patel Dinesh V Ph D · Sep 8, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Aug 13, 2026
- Form 4 · Patel Dinesh V Ph D · Aug 12, 2026